Jul 19, 2025, 22:37

CRUK Early Detection & Diagnosis Primer Award

Early Detection & Diagnosis Primer Award is a seed-funding up to £100 000 for up to one year to empower researchers (new to or established in ED&D) to pursue high-risk, high-reward pilot studies, forge novel collaborations, and generate proof-of-principle data that will catalyse future work in cancer early detection and diagnosis.

Eligibility Criteria:

Career Stage: Early-career, mid-career or established researchers; clinicians, non-clinical scientists or healthcare professionals.
Experience: At least some postdoctoral or equivalent research experience.
Host Institution: Based at a UK university, medical school, hospital or research institute.
Scope:
- Novel ideas or technologies with clear line-of-sight to ED&D impact.
- Interdisciplinary or non-traditional cancer fields applying to ED&D.
Out of Remit:
- Studies without any plausible path to early detection impact.
- Population-level screening trials (see Prevention & Population schemes).

Funding Details:

Duration: Up to 1 year
Quantum: Up to £100 000, covering:
- Salaries for postdocs or technical support staff
- Consumables, reagents, pilot experiments
- Equipment essential to the pilot work
- Collaborative travel, networking, training or exchange visits
Registered Reports Option: Teams may opt into CRUK’s multi-journal Registered Reports pilot.

Key Dates:

Full Submission Deadline: 18 September 2025
Committee Review: November 2025
Next Round (TBC): March 2026 (decision May 2026)

How to Apply & Further Information:

Pre-application Discussion: Contact the ED&D Research Grants Manager more than 2 weeks before deadline to confirm eligibility and fit.
Submit Online: Complete and submit via Flexi-Grant; your Host Institution must approve before the deadline.
Guidance & Conditions: Download the application guidelines and cost guidance from the CRUK website.
Contacts:
- London & South England (incl. Oxford/Cambridge): Sara Castro — [email protected]
- Rest of UK: Emily Friar — [email protected]

Cancer Diagnosis Cancer research Collaboration CRUK early detection ed&d Engineering Innovation Multidisciplinary physical-sciences pilot funding primer award project award Seed Grant UK funding UK researcher

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Matt Sherer: ASCO Supports Permanent Medicare Telehealth